Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
-immunotherapyoptical-crispr-scr… Requirements Additional Information Website for additional job details https://jobs.dkfz.de/en/jobs/168884/phd-student-immunotherapyoptical-crispr-scr… Work Location(s
-
laboratory of Dr. Lindsay Rizzardi ( https://sites.uab.edu/rizzardilab ) a research team that explores how genetic variation impacts cell type-specific gene regulation in the context of neuro-related
-
data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies Skip to main content Postdoctoral Researcher – Genome-wide CRISPR Screening of
-
University Medical Centre Groningen (UMCG) | Groningen, Provincie Groningen | Netherlands | 17 days ago
-generation technologies aimed at assessing, protecting, and repairing donor livers before transplantation. This PhD project is embedded within the multidisciplinary CRISPR-CRYSTAL consortium, bringing
-
. Nesbitt, JILA/Department of Chemistry/Department of Physics Biophysics, single molecule microscopy, FRET, time correlated single photon counting, nucleoproteins, CRISPR/CAS9, riboswitches, high pressure The
-
Lab Technician for In Vivo Multiplexed CRISPR Screening Ghent VIB Center for Inflammation Research Lab Technician / Support Posted Date 18 Sep 2026 Locations Ghent Center VIB Center for Inflammation
-
Status: Exempt Work Schedule: Monday – Friday, 8 a.m. – 5 p.m. Summary The Center for Drug Discovery ( https://www.bcm.edu/research/centers/drug-discovery) is a strategic research center at Baylor
-
– inflammation – infection – streptococcus – CRISPR/Cas9 – proteomics – targeted therapy Website of the “Cell Signaling and Pathogenesis” team: https://cimiparis.fr/equipes/robert-weil/ Where to apply
-
PhD/Postdoc in In Vivo CRISPR Screening (Dry and/or Wet Lab) Ghent VIB Center for AI & Computational Biology PhD/Post-doctoral Posted Date 18 Sep 2026 Locations Ghent Center VIB Center for AI
-
regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with severe diseases. In fact, Intellia's co-founder Jennifer Doudna along with Emmanuelle